Detalhe da pesquisa
1.
Plasma cell emperipolesis in multiple myeloma.
Br J Haematol
; 198(6): 937, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35852921
2.
The expression of Death Inducer-Obliterator (DIDO) variants in Myeloproliferative Neoplasms.
Blood Cells Mol Dis
; 59: 25-30, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27282563
3.
ROR1 expression in mature B lymphoid neoplasms by flow cytometry.
Cytometry B Clin Cytom
; 106(1): 74-81, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38273649
4.
Corrigendum to "The expression of Death Inducer-Obliterator (DIDO) variants in Myeloproliferative Neoplasms" [Blood Cells Mol. Dis. 59 (2016) 25-30].
Blood Cells Mol Dis
; 69: 123, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28882478
5.
Hippo pathway-related genes expression is deregulated in myeloproliferative neoplasms.
Med Oncol
; 39(5): 97, 2022 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35599283
6.
Bone Marrow Soluble Mediator Signatures of Patients With Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.
Front Oncol
; 11: 665037, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34084749
7.
Updating recommendations of the Brazilian Group of Flow Cytometry (GBCFLUX) for diagnosis of acute leukemias using four-color flow cytometry panels.
Hematol Transfus Cell Ther
; 43(4): 499-506, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34127423
8.
Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation.
Hematol Transfus Cell Ther
; 40(2): 120-131, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30057985
9.
Updating recommendations of the Brazilian Group of Flow Cytometry (GBCFLUX) for diagnosis of acute leukemias using four-color flow cytometry panels
Hematol., Transfus. Cell Ther. (Impr.)
; 43(4): 499-506, Oct.-Dec. 2021. tab
Artigo
em Inglês
| LILACS | ID: biblio-1350821
10.
Proposal for the standardization of flow cytometry protocols to detect minimal residual disease in acute lymphoblastic leukemia.
Rev Bras Hematol Hemoter
; 37(6): 406-13, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26670404
11.
Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation
Hematol., Transfus. Cell Ther. (Impr.)
; 40(2): 120-131, Apr.-June 2018. tab, graf, ilus
Artigo
em Inglês
| LILACS | ID: biblio-953824
12.
Apoptosis- and cell cycle-related genes methylation profile in myeloproliferative neoplasms.
Leuk Lymphoma
; 57(5): 1201-4, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26437212
13.
Differential expression of apoptosis-related genes from death receptor pathway in chronic myeloproliferative diseases.
J Clin Pathol
; 64(1): 75-82, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21045235
14.
Proposal for the standardization of flow cytometry protocols to detect minimal residual disease in acute lymphoblastic leukemia
Rev. bras. hematol. hemoter
; 37(6): 406-413, Oct.-Dec. 2015. tab, graf
Artigo
em Inglês
| LILACS | ID: lil-769968
15.
Deregulated expression of A1, Bcl-2, Bcl-xL, and Mcl-1 antiapoptotic proteins and Bid, Bad, and Bax proapoptotic genes in polycythemia vera patients
Braz. j. pharm. sci
; 47(4): 873-886, Oct.-Dec. 2011. graf, tab
Artigo
em Inglês
| LILACS | ID: lil-618081
16.
Chronic myeloid leukemia (CML): prognostic factors and survival analysis
São Paulo med. j
; 114(1): 1083-1090, Jan.-Feb. 1996. tab, graf
Artigo
em Inglês
| LILACS | ID: lil-173538
17.
Myelodysplastic syndromes (MDS): prognostic factors and scoring systems
São Paulo med. j
; 115(5): 1537-41, set.-out. 1997. tab
Artigo
em Inglês
| LILACS | ID: lil-209336